BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Business

  MedImmune, Inc. Licenses Xencor’s XmAb(TM) Technology To Create Antibody Therapeutics Against Select Tumor Targets

  December 7, 2005

   · 

  1 min read
• Bio NC

  Quintiles Medical Communications Announces New Structure

  December 7, 2005

   · 

  2 min read
• Genetown

  Domantis Limited’ Dual Targeting Domain Antibodies Shown To Kill Multiple Myeloma Cells And Spare Healthy Cells

  December 7, 2005

   · 

  4 min read
• Drug Development

  The Medicines Company Completes Enrollment Of 13,800-Patient ACUITY Trial Of Angiomax(R) (bivalirudin)

  December 7, 2005

   · 

  1 min read
• BioCapital

  Advancis Pharmaceutical Corporation To Present At NYSSA Biotech/Specialty Pharma Conference

  December 7, 2005

   · 

  2 min read
• Business

  Celladon Corporation Secures $30 Million In Series B Financing

  December 7, 2005

   · 

  1 min read
• Business

  Sunesis Pharmaceuticals, Inc. Receives Milestone Payment From Biogen Idec, Inc. (Massachusetts)

  December 7, 2005

   · 

  1 min read
• Pharm Country

  OptiCare Health Systems, Inc. Announces Departure Of CEO, President And General Counsel Christopher J. Walls; Names Dean J. Yimoyines, M.D. As Interim Chief Executive Officer

  December 7, 2005

   · 

  3 min read
• Genetown

  ArQule, Inc. Updates Plans For Chemical Technologies Business

  December 7, 2005

   · 

  1 min read
• Drug Development

  Antigenics Inc. (New York) Updates Business Strategy, Outlines Timeline For The Analysis Of Its Phase 3 Kidney Cancer Trial; 81 Jobs Cut

  December 7, 2005

   · 

  1 min read